Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 633 | 200 | 200 | 200 | 200 |
| Gross Profit | 633 | 200 | 200 | 200 | 200 |
| Operating Expenses | 12,575 | 11,377 | 9,984 | 6,919 | 9,315 |
| Operating Income | -11,942 | -11,177 | -9,784 | -6,719 | -9,115 |
| Other Income | 5,849 | 5,601 | 73 | -2,184 | -7,598 |
| Pre-tax Income | -6,093 | -5,576 | -9,711 | -8,903 | -16,713 |
| Net Income Continuous | -6,093 | -5,576 | -9,711 | -8,903 | -16,713 |
| Net Income | $-6,093 | $-5,576 | $-9,711 | $-8,903 | $-16,713 |
| EPS Basic Total Ops | -9.00 | -9.00 | -14.99 | -13.49 | -29.99 |
| EPS Basic Continuous Ops | -9.10 | -8.32 | -14.53 | -12.62 | -30.13 |
| EPS Diluted Total Ops | -9.00 | -9.00 | -14.99 | -13.49 | -29.99 |
| EPS Diluted Continuous Ops | -9.10 | -8.32 | -14.53 | -12.62 | -30.13 |
| EBITDA(a) | $-11,820 | $-11,084 | $-9,660 | $-6,563 | $-8,929 |